Abstract | PURPOSE: METHODS: RESULTS: We compared 5,10-methylenetetrahydrofolate reductase genotypes in groups of subjects presenting ischemic stroke (n = 127) and normal control (n = 126) and found an odds ratio of 1.97 (95% CI, 0.84-4.64) in a multivariate analysis in which results were adjusted to baseline clinical characteristics of study participants. CONCLUSION:
|
Authors | Suely Kazue Nagahashi Marie, Samuel Katsuyuki Shinjo, Sueli Mieko Oba-Shinjo, Roseli da Silva, Keila Cardoso Barbosa, Fabio Yamamoto, Milberto Scaff |
Journal | Clinics (Sao Paulo, Brazil)
(Clinics (Sao Paulo))
Vol. 62
Issue 3
Pg. 295-300
(Jun 2007)
ISSN: 1807-5932 [Print] United States |
PMID | 17589670
(Publication Type: Journal Article)
|
Chemical References |
- Genetic Markers
- Methylenetetrahydrofolate Reductase (NADPH2)
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Brain Ischemia
(genetics)
- Case-Control Studies
- Female
- Genetic Markers
(genetics)
- Genetic Predisposition to Disease
(genetics)
- Genotype
- Humans
- Male
- Methylenetetrahydrofolate Reductase (NADPH2)
(genetics)
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Polymorphism, Genetic
(genetics)
- Risk Factors
|